Amsterdam Academic Ventures

Amsterdam Innovations, Global Impact

Amsterdam Academic Ventures (AAV) builds, supports and funds companies that are based on science from Amsterdam’s knowledge institutes. Our ventures help bridge the gap between academia and society, ensuring that groundbreaking innovations create meaningful impact.

Our portfolio

Meet our most recent ventures

Pepper Therapeutics

Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer

Flowsure

Automating urine output monitoring for hospitalized patients.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.

Our latest news

Stay up to date

February 23, 2026

InvestmentNew venture

Amplio Pharma B.V. recently completed a second closing within their Seed Investment Round in support of the clinical development of NovoBioJect for the treatment of rheumatoid arthritis

February 18, 2026

In the media

Amsterdam UMC spin-off RSouth is making a big impact on infant health and ICU admissions in the Netherlands

December 18, 2025

Collaboration Leads to the Incoporation of Pepper Therapeutics: New Research into the Treatment of Pancreatic Cancer

About AAV

About Amsterdam Academic Venture

Amsterdam Academic Ventures (AAV) is dedicated to transforming groundbreaking academic research from Amsterdam-based knowledge institutes into successful ventures. AAV builds, supports and invests in spin-offs from the following institutes:

Amsterdam University Medical Center (Amsterdam UMC)

Amsterdam University of Applied Sciences (AUAS)

University of Amsterdam (UvA)

Learn more

Ready for your next step?

Are you looking for an innovative startup to invest in, work for or collaborate with?

Is your startup looking for funding? Find out what AAV can do for you?